The "Global Intrauterine Contraceptive Devices (IUD) Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The intrauterine contraceptive devices (IUD) market is poised to grow by $ 597.40 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period.
The market is driven by the initiatives taken by governments and non-profit organizations and the effectiveness of IUDs.
The report on the intrauterine contraceptive devices (IUD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The intrauterine contraceptive devices (IUD) market analysis includes end-user segment and geographical landscapes.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intrauterine contraceptive devices (IUD) market vendors that include AbbVie Inc., Bayer AG, DKT International, EUROGINE SL, Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Mylan NV, Pregna International Ltd., Prosan International BV, and The Cooper Companies Inc.
Also, the intrauterine contraceptive devices (IUD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Value chain analysis
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by End-user
Comparison by End-user
Hospitals - Market size and forecast 2019-2024
Gynecology clinics - Market size and forecast 2019-2024
Others - Market size and forecast 2019-2024
Market opportunity by End-user
Market Segmentation by Type
Comparison by Type
Hormonal intrauterine device - Market size and forecast 2019-2024
Copper intrauterine device - Market size and forecast 2019-2024
Market opportunity by Type
Europe - Market size and forecast 2019-2024
North America - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Market positioning of vendors
Laboratoire HRA Pharma SAS
Melbea Innovations Ltd.
Pregna International Ltd.
Prosan International BV
The Cooper Companies Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9wz9od.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413006020/en/
Laura Wood, Senior Press Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900